Associate 
Janet Worrell is an independent Regulatory Affairs Specialist, at consult2deliver limited, a consultancy based in BioCity Nottingham. She began crafting her regulatory skills at Thomas Kerfoot and Medeva in Ashton under Lyne, before moving to 3M as the global regulatory lead for Qvar, the first CFC free beclomethasone inhaler.
Her first role in OTC medicines began at Boots the Chemists, gaining approval of new consumer medicines for the new Republic of Ireland stores, before transferring to senior roles within Boots Healthcare International, supporting Strepsils globally. Operational roles combined with Global Regulatory responsibilities saw a return to inhaled drug development with Vectura. Latterly at Boots Pharmaceuticals she was the Head of Innovative Regulatory Affairs, assessing solutions for consumers in healthcare, covering medical devices, food supplements through to reclassification strategies. She continues to work within this stimulating space.
